Safak Sahiner-Yalcın
Ankara, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Psychological Profile of Bariatric Surgery Candidates: A Cross-Sectional Study.
Journal: Brain and behavior
Published: May 21, 2026
An investigation of university students' perspectives on combating addiction: a qualitative study.
Journal: Frontiers in public health
Published: April 20, 2026
Sublingual buprenorphine/naloxone treatment is not affected by OPRM1 A118G and BDNF Va66Met polymorphisms, but alters the plasma beta-endorphin and BDNF levels in individuals with opioid use disorder.
Journal: Environmental toxicology and pharmacology
Published: June 23, 2022
Effects of UGT2B7 rs7662029 and rs7439366 polymorphisms on sublingual buprenorphine metabolism in heroin addicts: An improved PCR-RFLP assay for the detection of rs7662029 polymorphism.
Journal: Environmental toxicology and pharmacology
Published: February 11, 2022
Association of PDYN 68-bp VNTR polymorphism with sublingual buprenorphine/naloxone treatment and with opioid or alcohol use disorder: Effect on craving, depression, anxiety and age onset of first use.
Journal: European journal of pharmacology
Published: December 18, 2021
Association of Glial Cell-Line Derived Neurotrophic Factor and Nerve Growth Factor with Duration of Untreated Psychosis and Clinical Symptoms in Drug-Naive Schizophrenia.
Journal: Psychiatry and clinical psychopharmacology
Published: February 25, 2021
DTI-MRI findings in synthetic cannabinoid users
Journal: Turkish journal of medical sciences
Published: May 01, 2019
Association of serum brain derived neurotropic factor with duration of drug-naive period and positive-negative symptom scores in drug naive schizophrenia.
Journal: PloS one
Published: January 08, 2017
TNF-related weak inducer of apoptosis (TWEAK) levels in schizophrenia.
Journal: Psychiatry research
Published: February 05, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026